Related Experiment Video

Updated: Feb 18, 2026

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.5K

Considerations About the Use of Biomarkers in Cancer Clinical Trials

Bruce A Chabner1

  • 1Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Clinical Pharmacology and Therapeutics
|November 15, 2017
PubMed

Insights

Understanding cancer biology advances patient care, from early detection to targeted drug development. Biomarkers identify key mutations, guiding patient selection for novel cancer therapies targeting specific oncogenic pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Translational Medicine

Background:

  • Cancer biology understanding has rapidly evolved, impacting all patient management phases.
  • Biomarker identification of tumor-driving mutations is crucial for personalized medicine.
  • Novel cancer drugs often target specific oncogenic pathways.

Purpose of the Study:

  • To highlight the importance of biomarkers in modern cancer management.
  • To discuss the role of biomarkers in patient selection for targeted therapies.
  • To underscore the connection between cancer biology, biomarkers, and drug development.

Main Methods:

  • Review of current literature on cancer biology and biomarker discovery.
  • Analysis of the role of biomarkers in clinical trial patient stratification.
  • Examination of the impact of molecular diagnostics on cancer treatment selection.

Main Results:

  • Biomarkers are essential for identifying actionable mutations in tumors.
  • Biomarker-driven patient selection enhances the efficacy of targeted cancer drugs.
  • Advances in molecular assays improve the identification of targetable oncogenic pathways.

Conclusions:

  • The integration of cancer biology insights and biomarker analysis is transforming oncology.
  • Biomarkers are pivotal in advancing precision medicine and optimizing cancer drug development.
  • Effective use of biomarkers facilitates the clinical application of targeted oncogenic pathway inhibitors.

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.2K
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.7K

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
488
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
787